Grown Rogue International (GRUSF) Cash from Investing Activities Growth (1y) (2014 - 2026)
Grown Rogue International (GRUSF) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | -761.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -761.12% |
| Dec 31, 2025 | 103,863,188.84% |
| Mar 31, 2025 | 86.14% |
| Jan 31, 2023 | 94.08% |
| Jan 31, 2022 | -186.49% |
| Oct 31, 2021 | -31,675,123.84% |
| Jul 31, 2021 | -2,226.00% |
| Apr 30, 2021 | 293.50% |
| Jan 31, 2021 | -3,411.84% |
| Oct 31, 2020 | -7,006.72% |
| Jul 31, 2020 | 402.04% |
| Apr 30, 2020 | 436.93% |
| Jan 31, 2020 | 94.45% |
| Oct 31, 2019 | 106.10% |
| Jul 31, 2019 | -152.51% |
| Apr 30, 2019 | 6.91% |
| Jan 31, 2019 | 89.28% |
| Aug 31, 2015 | -233.49% |
| May 31, 2015 | 205.23% |
| Nov 30, 2014 | -163.38% |